Am I eligible for a GLP-1?
Free. Nothing you enter leaves your browser. Checked October 18, 2026.
What the labels say, and where the numbers come from
Labels for weight-management medicines no longer print a BMI number. They say the medicine is for adults with obesity, or with overweight and at least one weight-related condition. The figures everyone quotes, 30, or 27 with a condition, are who the clinical trials enrolled. Insurers and Medicare reuse them, sometimes with higher bars, which is why a plan can say no to someone a prescriber would treat.
Approved for weight, as of October 2026
| Medicine | How it is taken | Who | Also approved for |
|---|---|---|---|
| Zepbound tirzepatide | Weekly injection: single-dose pen, single-dose vial or KwikPen (4 doses) | Adults only | Moderate to severe obstructive sleep apnea in adults with obesity |
| Wegovy semaglutide | Weekly injection: single-dose pen (FlexTouch for HD 7.2 mg) | Adults, and children 12 and older | Lowering the risk of heart attack, stroke and cardiovascular death in adults with established heart disease and obesity or overweight; Noncirrhotic MASH (fatty liver disease) with moderate to advanced fibrosis in adults |
| Wegovy pill semaglutide | Daily tablet, taken in the morning on an empty stomach with up to 4 oz of water, then 30 minutes before food or drink | Adults only | Lowering cardiovascular risk |
| Foundayo orforglipron | Daily tablet, any time of day, with or without food | Adults only | None |
| Saxenda liraglutide | Daily injection: multi-dose pens | Adults, and children 12 and older over 60 kg | None In limited supply and due to be discontinued in January 2027 (FDA shortage database). A generic liraglutide for weight management was approved in August 2025. |
Next
If your answers match, the next questions are who prescribes it and who pays. How to get a GLP-1 in the US walks through both, and the cost calculator puts every price side by side.
Questions people ask
What BMI do you need for a GLP-1?
The current FDA labels for Wegovy, Zepbound and Foundayo say adults with obesity, or overweight with at least one weight-related condition. The trials behind them enrolled people with a BMI of 30 or more, or 27 or more with a condition such as high blood pressure, high cholesterol, type 2 diabetes, sleep apnea or heart disease, and most insurers use those numbers.
Can I get a GLP-1 with a BMI under 27?
Not for weight management under the label. If you have type 2 diabetes, medicines such as Ozempic and Mounjaro are approved for blood sugar control at any weight, and that decision is your prescriber's.
Does Medicare cover weight-loss GLP-1s now?
Through the Medicare GLP-1 Bridge, from 1 July 2026 to 31 December 2027, eligible Part D enrollees pay $50 a fill for Wegovy (injection or tablets), Foundayo, and the Zepbound KwikPen only (not Zepbound single-dose pens or vials). The BMI rules are stricter than the labels: 35 or more, or lower with specific heart, blood pressure, kidney or blood sugar conditions.
More free tools
- How to get a GLP-1 in the USYour route from first question to first dose, for your coverage.
- Insurance checkerWhat your kind of plan usually covers, and what to ask.
- Appeal letter writerA denial letter answered, ready to send. Nothing you type is stored.
- Cost and budget calculatorEvery way to pay, side by side, for a month and a year.
- Supply and refill plannerWhen your pens run out, when to reorder, and the national supply.
- GLP-1 diet calculatorYour calories, protein and three days of food for your dose.
Sources, checked October 18, 2026
- Wegovy prescribing information, DailyMed (revised June 2026)
- Zepbound prescribing information, DailyMed (revised August 2026)
- Foundayo prescribing information, DailyMed (revised July 2026)
- Saxenda prescribing information, DailyMed (revised February 2026)
- FDA: first medication for obstructive sleep apnea (20 December 2024)
- CMS: Medicare GLP-1 Bridge
- CMS: GLP-1 Bridge information for prescribers (June 2026)
- Medicare.gov: weight-loss drugs
General information for people in the United States, not medical, legal or insurance advice. Prices and plan rules change; the source links above are the final word. foodose does not prescribe, sell or dispense medicine, and is not affiliated with Novo Nordisk or Eli Lilly.